Japan Nuclear Medicine Market - 2024-2031
Japan Nuclear Medicine Market reached US$ 550.3 million in 2023 and is expected to reach US$ 2,543.2 million by 2031, growing with a CAGR of 21.20% during the forecast period 2026-2031.
The Japan Nuclear Medicine Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A Japan Nuclear Medicine Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Product Type
Both primary and secondary data sources have been used in the global Japan Nuclear Medicine Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
The Japan Nuclear Medicine Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A Japan Nuclear Medicine Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Product Type
- General and Diagnostic Equipment*
- Diagnostics
- Single Photon Emission Computed Tomography (SPECT)
- Technetium-99m (Tc-99m)
- Thallium-201 (Tl-201)
- Gallium-67 (Ga-67)
- Iodine-123 (I-123)
- Others
- Positron Emission Tomography (PET)
- Fluorine-18 (F-18)
- Rubidium-82 (Rb-82)
- Therapeutics
- Alpha Emitters
- Radium-223 (Ra-223)
- Beta Emitters
- Iodine-131 (I-131)
- Yttrium-90 (Y-90)
- Lutetium-177 (Lu-177)
- Brachytherapy Isotopes
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Diagnostic Procedures*
- SPECT Procedures
- PET Procedures
- Therapeutic Procedures
- Cardiology*
- Oncology
- Neurology
- Thyroid Disorders
- Endocrine Tumors
- Lymphoma and Bone Metastasis
- Pulmonary Scans
- Urology
- Others
- Hospitals *
- Diagnostic Centers
- Others
- Go-to-market Strategy.
- Neutral perspective on the market performance.
- Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
- Customized regional/country reports as per request and country level analysis.
- Potential & niche segments and regions exhibiting promising growth covered.
- Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Both primary and secondary data sources have been used in the global Japan Nuclear Medicine Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Product Type
3.2. Snippet by Procedural Volume Assessment
3.3. Snippet by Application
3.4. Snippet by End-User
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Prevalence of Cancer and Cardiac Disorders and
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. High Cost of Radiopharmaceuticals
4.1.3. Opportunity
5. IMPACT ANALYSIS
6. INDUSTRY ANALYSIS
6.1. Porter’s Five Force Analysis
6.2. Supply Chain Analysis
6.3. Pricing Analysis
6.4. Patent Analysis
6.5. Regulatory Analysis
6.6. SWOT Analysis
6.7. Unmet Needs
7. BY PRODUCT TYPE
7.1. Introduction
7.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. General and Diagnostic Equipment*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Diagnostics
7.3.1. Single Photon Emission Computed Tomography (SPECT)
7.3.2. Technetium-99m (Tc-99m)
7.3.3. Thallium-201 (Tl-201)
7.3.4. Gallium-67 (Ga-67)
7.3.5. Iodine-123 (I-123)
7.3.6. Others
7.3.7. Positron Emission Tomography (PET)
7.3.8. Fluorine-18 (F-18)
7.3.9. Rubidium-82 (Rb-82)
7.3.10. Others
7.4. Therapeutics
7.4.1. Alpha Emitters
7.4.2. Radium-223 (Ra-223)
7.4.3. Others
7.4.4. Beta Emitters
7.4.5. Iodine-131 (I-131)
7.4.6. Yttrium-90 (Y-90)
7.4.7. Lutetium-177 (Lu-177)
7.4.8. Others
7.4.9. Brachytherapy Isotopes
7.4.10. Cesium-131
7.4.11. Iodine-125
7.4.12. Palladium-103
7.4.13. Iridium-192
7.4.14. Others
8. BY PROCEDURAL VOLUME ASSESSMENT
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedural Volume Assessment
8.1.2. Market Attractiveness Index, By Procedural Volume Assessment
8.2. Diagnostic Procedures*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.2.3. SPECT Procedures
8.2.4. PET Procedures
8.3. Therapeutic Procedures
9. BY APPLICATION
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Cardiology*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Oncology
9.4. Neurology
9.5. Thyroid Disorders
9.6. Endocrine Tumors
9.7. Lymphoma and Bone Metastasis
9.8. Pulmonary Scans
9.9. Urology
9.10. Others
10. BY END-USER
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals *
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Diagnostic Centers
10.4. Others
11. COMPETITIVE LANDSCAPE
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. COMPANY PROFILES
12.1. GE Healthcare*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Fujifilm (FUJIFILM Toyama Chemical Co. Ltd)
12.3. Siemens Healthineers
12.4. Bracco
12.5. CANON MEDICAL SYSTEMS CORPORATION
12.6. Nihon Medi-Physics Co. (Sumitomo Chemical Co. Ltd)
12.7. ATOX CO., Ltd.
12.8. IBA Radiopharma Solutions
12.9. JFE Engineering Corporation
12.10. Koninklijke Philips N.V. (*LIST NOT EXHAUSTIVE)
13. APPENDIX
13.1. About Us and Services
13.2. Contact Us
Suggestions for Related Report
• Nuclear Imaging Equipment Market (https://www.datamintelligence.com/research-report/nuclear-imaging-equipment-market)
• Nuclear Medicine Radioisotopes Market (https://www.datamintelligence.com/research-report/nuclear-medicine-radioisotopes-market)
• Global Micro Nuclear Reactors (MNRs) Market (https://www.datamintelligence.com/research-report/micro-nuclear-reactors-market)
For more pharmaceuticals-related reports, please click here (https://www.datamintelligence.com/industry-verticals/pharmaceuticals)
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Product Type
3.2. Snippet by Procedural Volume Assessment
3.3. Snippet by Application
3.4. Snippet by End-User
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Prevalence of Cancer and Cardiac Disorders and
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. High Cost of Radiopharmaceuticals
4.1.3. Opportunity
5. IMPACT ANALYSIS
6. INDUSTRY ANALYSIS
6.1. Porter’s Five Force Analysis
6.2. Supply Chain Analysis
6.3. Pricing Analysis
6.4. Patent Analysis
6.5. Regulatory Analysis
6.6. SWOT Analysis
6.7. Unmet Needs
7. BY PRODUCT TYPE
7.1. Introduction
7.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. General and Diagnostic Equipment*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Diagnostics
7.3.1. Single Photon Emission Computed Tomography (SPECT)
7.3.2. Technetium-99m (Tc-99m)
7.3.3. Thallium-201 (Tl-201)
7.3.4. Gallium-67 (Ga-67)
7.3.5. Iodine-123 (I-123)
7.3.6. Others
7.3.7. Positron Emission Tomography (PET)
7.3.8. Fluorine-18 (F-18)
7.3.9. Rubidium-82 (Rb-82)
7.3.10. Others
7.4. Therapeutics
7.4.1. Alpha Emitters
7.4.2. Radium-223 (Ra-223)
7.4.3. Others
7.4.4. Beta Emitters
7.4.5. Iodine-131 (I-131)
7.4.6. Yttrium-90 (Y-90)
7.4.7. Lutetium-177 (Lu-177)
7.4.8. Others
7.4.9. Brachytherapy Isotopes
7.4.10. Cesium-131
7.4.11. Iodine-125
7.4.12. Palladium-103
7.4.13. Iridium-192
7.4.14. Others
8. BY PROCEDURAL VOLUME ASSESSMENT
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedural Volume Assessment
8.1.2. Market Attractiveness Index, By Procedural Volume Assessment
8.2. Diagnostic Procedures*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.2.3. SPECT Procedures
8.2.4. PET Procedures
8.3. Therapeutic Procedures
9. BY APPLICATION
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Cardiology*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Oncology
9.4. Neurology
9.5. Thyroid Disorders
9.6. Endocrine Tumors
9.7. Lymphoma and Bone Metastasis
9.8. Pulmonary Scans
9.9. Urology
9.10. Others
10. BY END-USER
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals *
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Diagnostic Centers
10.4. Others
11. COMPETITIVE LANDSCAPE
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. COMPANY PROFILES
12.1. GE Healthcare*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Fujifilm (FUJIFILM Toyama Chemical Co. Ltd)
12.3. Siemens Healthineers
12.4. Bracco
12.5. CANON MEDICAL SYSTEMS CORPORATION
12.6. Nihon Medi-Physics Co. (Sumitomo Chemical Co. Ltd)
12.7. ATOX CO., Ltd.
12.8. IBA Radiopharma Solutions
12.9. JFE Engineering Corporation
12.10. Koninklijke Philips N.V. (*LIST NOT EXHAUSTIVE)
13. APPENDIX
13.1. About Us and Services
13.2. Contact Us
Suggestions for Related Report
• Nuclear Imaging Equipment Market (https://www.datamintelligence.com/research-report/nuclear-imaging-equipment-market)
• Nuclear Medicine Radioisotopes Market (https://www.datamintelligence.com/research-report/nuclear-medicine-radioisotopes-market)
• Global Micro Nuclear Reactors (MNRs) Market (https://www.datamintelligence.com/research-report/micro-nuclear-reactors-market)
For more pharmaceuticals-related reports, please click here (https://www.datamintelligence.com/industry-verticals/pharmaceuticals)
